https://www.taxtmi.com/caselaws?id=339236 The Tribunal classified the medicaments as patent or proprietary medicines under Chapter heading 3003.10, allowing the appellant to claim Cenvat Credit. The Tribunal determined that the names of the medicaments were not listed in any pharmacopeia but were created as brand names for the buyer, supporting their classification as patent or proprietary medicines. Consequently, the original order demanding Cenvat Credit on inputs used in the medicaments was overturned, and the appeal was allowed in favor of the appellant. en-us Thu, 19 Jan 2017 00:00:00 +0530 Mon, 21 Aug 2017 14:41:00 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=339236 The Tribunal classified the medicaments as patent or proprietary medicines under Chapter heading 3003.10, allowing the appellant to claim Cenvat Credit. The Tribunal determined that the names of the medicaments were not listed in any pharmacopeia but were created as brand names for the buyer, supporting their classification as patent or proprietary medicines. Consequently, the original order demanding Cenvat Credit on inputs used in the medicaments was overturned, and the appeal was allowed in favor of the appellant. Case-Laws Central Excise Thu, 19 Jan 2017 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=339236